Cite
HARVARD Citation
Jordan, S. et al. (2020). Intravenous immunoglobulin significantly reduces exposure of concomitantly administered anti‐C5 monoclonal antibody tesidolumab. American journal of transplantation. 20 (9), pp. 2581-2588. [Online].